Skip to content
DraconiticResearch
Search Sources API
211,646 studies31 sourcesUpdated 5 min ago

Oncology

5,331 studies510 in 7 days2,567 in 30 days

Atom feed
Filters
Type
Date
Clear

Latest

5,331 studies

NewestMost cited
  1. Catalytically inactive PARP1 protein drives PARP inhibitor induced hematological toxicity
    X. Lin, Z. Shao, D. Yaneva +9
    bioRxivPreprintCC BYFull textOncologybioRxiv
  2. MAPK signaling links BRD2 chromatin occupancy to PI3K/AKT inhibitor sensitivity
    J. Mendez, S. Bruno, A. Indeglia +12
    bioRxivPreprintCC BY-NC-NDFull textOncologybioRxiv
  3. Neuroblastoma-derived small extracellular vesicles retaincellular identity and adrenergic/mesenchymal state signatures
    M. Grimaldi, M. Kirchner, A. Szymansky +8
    bioRxivPreprintAll rights reservedFull textOncologybioRxiv
  4. Bispecific GD2xB7-H3 Antibody Improves Tumor Targeting and Reduces Toxicity while Maintaining Efficacy for Neuroblastoma
    A. Erbe, A. Feils, S. Reinthaler +27
    bioRxivPreprintCC BY-NC-NDFull textOncologybioRxiv
  5. Amyloid precursor protein. An Achilles heel to exploit in the treatment of prostate cancer
    M. Alhadrami, E. Gill, C. M. Perks +1
    bioRxivPreprintCC BYFull textOncologybioRxiv
  6. A tumor-cell MHC-II program is associated with checkpoint-blockade outcomes across stages of bladder cancer
    J. Bellmunt, Y. Xie, M. Gomez Munoz +20
    bioRxivPreprintCC BY-NC-NDFull textOncologybioRxiv
  7. Dual-targeted nanoparticles enable the ex vivo generation of cytotoxic and phagocytic CAR effector cells
    J. Hong, J. Lim, M. Park +8
    bioRxivPreprintCC BY-NC-NDFull textOncologybioRxiv
  8. Differential Cytotoxicity of PVP-Copper Nanoparticles in Breast Cancer Cell Lines: Insights from Basal Transcriptomic Profiles
    A. Goncalves Silva, I. J. Oliveira Silva, P. Paranhos Tanaka +6
    bioRxivPreprintCC BYFull textOncologybioRxiv
  9. Mapping Colorectal Practice Patterns in a Community Hospital: A Correspondence Analysis Approach.
    Timothy W Gichuru, Abid Qureshi, Luca Milone
    CureusPeer-reviewedCC BYFull textOncologyEurope PMC
  10. Effects of sensorimotor training on chemotherapy-induced peripheral neuropathy-related outcomes in adults with cancer: A systematic review and meta-analysis of randomized controlled trials.
    Quanping Lin, Lingna You, Liu Yang +5
    Asia-Pacific journal of oncology nursingPeer-reviewedCC BY-NC-NDFull textOncologyEurope PMC
  11. Potential five-year life years associated with stage IV reductions in NHS Galleri Trial
    N. Starasvetskaya, G. de Lima Lopes Junior
    medRxivPreprintCC BYFull textOncologymedRxiv
  12. Genomic foundation models extend clinicopathologic and transcriptomic prognostication in soft tissue sarcoma
    M. Esperanca-Martins, M. Sokolov Ravasqueira, S. Dias +3
    medRxivPreprintAll rights reservedFull textOncologymedRxiv
  13. Serum Cystatin 4 combined with routine clinical laboratory indicators: A support vector machine diagnostic model for early screening of gastrointestinal tumors
    Huijuan Bi, Lina Yin, Wenhao Fang +1
    PLOS OnePeer-reviewedCC BY 4.0Full textOncologyPLOS
  14. A quantitative treatment assessment for optimizing combined virotherapy-chemotherapy regimens against HPV-induced cervical cancer
    Salil Ghosh, Amit Kumar Bag, Satyajit Mukherjee +3
    PLOS OnePeer-reviewedCC BY 4.0Full textOncologyPLOS
  15. Phosphorylated HPV‑16 E7 disrupts planar cell polarity in cervical cancer cells through vangl1 dysregulation
    Ifeoluwa D. Gbala, Om Basukala, Amira Zine El Abidine +4
    PLOS PathogensPeer-reviewedCC BY 4.0Full textOncologyPLOS
  16. Development and validation of a nomogram predicting pathologic complete response to neoadjuvant chemotherapy in luminal type breast cancer patients using MammaPrint® and clinicopathological factor
    Sarah Al safi, Tae Kyung Yoo, Jisun Kim +6
    PLOS OnePeer-reviewedCC BY 4.0Full textOncologyPLOS
  17. Health-related quality of life with adjuvant immune checkpoint inhibition in renal cell carcinoma: A qualitative study of UK participants in the phase III RAMPART trial
    Sophie Merrick, Annabelle South, Elena Frangou +10
    PLOS OnePeer-reviewedCC BY 4.0Full textOncologyPharmacology & toxicologyPsychiatry & mental healthPLOS
  18. Application of symptom network analysis among patients with gastric cancer: A scoping review
    Qiu Zhu, Zijing Duan, Yi Dai +5
    PLOS OnePeer-reviewedCC BY 4.0Full textOncologyPLOS
  19. PAK4-targeting PROTAC inhibits bladder cancer cell proliferation
    Shan Xu, Hongjun Xie, Zhao Yang +5
    PLOS OnePeer-reviewedCC BY 4.0Full textOncologyPLOS
  20. Review of olfactory cleft roof anatomy
    M. Humbert, V. Bastit, M. Perreard +4
    European Annals of Otorhinolaryngology, Head and Neck DiseasesPeer-reviewedLicence not stated12 citedOncologyHAL
  21. Closure without epiglottoplasty or tracheotomy after reconstructive frontal anterior laryngectomy
    M.-C. Senol, V. Bastit, M. Humbert +2
    European Annals of Otorhinolaryngology, Head and Neck DiseasesPeer-reviewedLicence not statedOncologyHAL
  22. Treatment of epistaxis in Osler-Weber-Rendu disease by bevacizumab nasal spray. The EROSB study: Determining the effective dose
    L. Vincent, L. Robard, C. Creveuil +3
    European Annals of Otorhinolaryngology, Head and Neck DiseasesPeer-reviewedLicence not stated3 citedOncologyHAL
  23. A Cell-based Screening Method Using an Intracellular Antibody for Discovering Small Molecules Targeting Hard-to-drug Proteins
    Nicolas Bery, Terry H Rabbitts
    Bio-protocolPeer-reviewedLicence not stated5 citedOncologyHAL
  24. Platelet-programmed circulating tumor cells signal to monocytes through a candidate CD40LG-ITGA5:ITGB1 myeloid checkpoint axis in breast cancer
    S. Khoshbakht, H. Borna, M. Zarei +5
    bioRxivPreprintCC BY-NC-NDFull textOncologybioRxiv
  25. Zika virus oncolytic signaling reverts immunosuppressive and angiogenic glioblastoma microenvironment in vitro and in vivo
    G. Pinheiro Alves de Freitas, J. H. Quintanilla, J. M. Janeiro +14
    bioRxivPreprintCC BY-NC-NDFull textOncologybioRxiv